Options for Improved Platelet Safety Under the NEW DRAFT Guidance

Please note: AABB reserves the right to make further updates to this program. AABB will contact all registered participants with any program changes. If interested in current draft guidance, please consider AABB’s eCast “HOT TOPIC: FDA DRAFT Guidance on Bacterial Risk Control Strategies to Enhance Safety and Availability of Platelets: Pros and Cons of the Various Options

Wednesday, March 13, 2019 - [Rescheduled from 12/05/18]
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 18EL-385 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: CEOs, Director, Hospitals, Hospital Blood Banks, Managers/Supervisors, Medical Director, Physicians, Resident/Fellow, Scientist, Students (MD, MT, SBB), Transfusion Safety Officer
Teaching Level: Intermediate to Advanced

Director/Moderator: Eric A. Gehrie, MD, Assistant Professor, Pathology, Johns Hopkins University, Baltimore, MD
Speakers: To be Announced

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Discuss the risks posed to patients by bacteria in platelet components.
  • Appreciate the various technologies that can help to detect bacterial contamination of platelet concentrates.
  • Identify current regulatory guidance regarding the implementation of technologies intended to limit the exposure of transfusion recipients to platelets contaminated with platelets.
  • Have an action plan for compliance with regulatory requirements.

Program Description

For many years, bacterial contamination of platelets has been a major medical and regulatory concern. With the FDA approval of several different platforms (pathogen reduction technology, time of issue bacterial testing, etc.) that could be used to detect and/or limit exposure of patients to platelets contaminated with bacteria, the transfusion community is anticipating additional regulatory action/requirements. Final guidance is expected in 2019. This program will seek to explain the significance of the current guidance and BPAC conversations and outline ways for collection centers and hospital transfusion services to comply.​

Please note: AABB plans to offer an eCast on Implementing the Final Guidance on Enhancing PLT Safety after the final guidance is released (final guidance expected late 2019; eCast expected in 2020).


   Program #
Single Viewer: Live Register18EL-385-2035
Single Viewer: On-Demand Register18EL-385-4035
Group Viewing: Live Register18EL-385-6035
Group Viewing: On-Demand Register18EL-385-8035
Group Viewing: Live & On-Demand Register18EL-385-9935

Continuing Education Credit

AABB estimates both the live and on-demand version of this eCast each to be eligible for 1.5 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.